tiprankstipranks
ChromaDex reports Q3 EPS 2c, consensus 0c
PremiumThe FlyChromaDex reports Q3 EPS 2c, consensus 0c
20d ago
ChromaDex sees FY24 revenue growth 15%
Premium
The Fly
ChromaDex sees FY24 revenue growth 15%
20d ago
Is CDXC a Buy, Before Earnings?
Premium
Pre-Earnings
Is CDXC a Buy, Before Earnings?
23d ago
ChromaDex management to meet virtually with Roth MKM
PremiumThe FlyChromaDex management to meet virtually with Roth MKM
3M ago
Chromadex Shares Insightful Corporate Presentation Update
Premium
Company Announcements
Chromadex Shares Insightful Corporate Presentation Update
4M ago
ChromaDex sees FY24 revenue growth 10%-15%
Premium
The Fly
ChromaDex sees FY24 revenue growth 10%-15%
4M ago
ChromaDex to debut pharmaceutical-grade Niagen at clinics in August
PremiumThe FlyChromaDex to debut pharmaceutical-grade Niagen at clinics in August
4M ago
ChromaDex to be included in Russell 2000 Index
Premium
The Fly
ChromaDex to be included in Russell 2000 Index
5M ago
ChromaDex CFO Brianna Gerber Announces Resignation
Premium
Company Announcements
ChromaDex CFO Brianna Gerber Announces Resignation
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100